Parkin gene alterations in hepatocellular carcinoma
- 26 March 2004
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 40 (2) , 85-96
- https://doi.org/10.1002/gcc.20020
Abstract
The Parkin gene is an extremely large gene (1.5 Mb) within the highly unstable FRA6E common fragile site (CFS) region, which is frequently altered in ovarian, breast, and hepatocellular carcinomas. Because Parkin/FRA6E has genomic similarities to FHIT/FRA3B and WWOX/FRA16D, two other large tumor‐suppressor genes that are within CFS regions, we were interested in characterizing Parkin gene alterations and their possible association with cancer. After analyzing 50 cancer‐derived cell lines including 11 hepatocellular carcinoma (HCC) cell lines, we found that one HCC cell line, PLC/PRF/5, had a detectable homozygous deletion encompassing exon 3. Using quantitative duplex PCR and fluorescence in situ hybridization analysis to characterize the copy number changes of Parkin exons in HCC cell lines, we found that 4 of 11 HCC cell lines had heterozygous deletions of Parkin exons and one, Hep3B, had an exon duplication. Parkin protein expression was significantly decreased or absent in all 11 HCC cell lines. Furthermore, more than 50% of HCC primary tumors had decreased Parkin expression compared to that in normal liver tissue. Parkin gene–transfected PLC5 and Hep3B cells grew more slowly than vector‐only transfectants and also showed increased sensitivity to apoptosis induced by cell‐cycle inhibitors. Therefore, we suggest that Parkin may be involved in tumor suppression and that the loss of Parkin contributes to the development of hepatocarcinoma.Keywords
Funding Information
- NIH (CA48031)
- Department of Defense (DAMD 17-99-1-9504)
- Minnesota Ovarian Cancer Alliance
- DFG (Kl-1134/2-2)
This publication has 28 references indexed in Scilit:
- Alterations in the common fragile site gene Parkin in ovarian and other cancersOncogene, 2003
- Characterization of FRA6E and its potential role in autosomal recessive juvenile parkinsonism and ovarian cancerGenes, Chromosomes and Cancer, 2003
- Parkin , a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25–q27Proceedings of the National Academy of Sciences, 2003
- JNK1 Physically Interacts with WW Domain-containing Oxidoreductase (WOX1) and Inhibits WOX1-mediated ApoptosisJournal of Biological Chemistry, 2003
- Evidence that instability within the FRA3B region extends four megabasesOncogene, 2002
- Hint, Fhit, and GalT: Function, Structure, Evolution, and Mechanism of Three Branches of the Histidine Triad Superfamily of Nucleotide Hydrolases and TransferasesBiochemistry, 2002
- Evaluation of 50 probands with early-onset Parkinson’s disease for Parkin mutationsNeurology, 2002
- Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumorsOncogene, 2002
- The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset parkinsonismHuman Molecular Genetics, 2001
- Point Mutations (Thr240Arg and Ala311Stop) in theParkinGeneBiochemical and Biophysical Research Communications, 1998